B8252
Bromonucleic acid
Synonym(s):
2-Bromostearic Acid
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
41106305
PubChem Substance ID:
extent of labeling
~6% Br (by weight)
storage temp.
−20°C
Application
2-Bromostearate acid (bromonucleic acid) is used to inhibit fatty acid oxidation. 2-Bromostearate acid is a mitochondrial carnitine palmitoyltransferase I (CPT I) inhibitor.
Preparation Note
Bromination of yeast RNA.
Storage Class
13 - Non Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
C R Bliss et al.
The American journal of physiology, 263(5 Pt 1), E890-E896 (1992-11-01)
The development of glucose-stimulated insulin release and time-dependent potentiation (TDP) has been studied in isolated islets from 7-, 14-, and 21-day-old and 3-mo-old rats. Responses were small at 7 days and changed little at 14 days. At 21 days the
S Chen et al.
Diabetes, 43(7), 878-883 (1994-07-01)
We sought to explore the emerging concept that malonyl-CoA generation, with concomitant suppression of mitochondrial carnitine palmitoyltransferase I (CPT I), represents an important component of glucose-stimulated insulin secretion (GSIS) by the pancreatic beta-cell (Prentki M, Vischer S, Glennon MC, Regazzi
J Tamarit-Rodriguez et al.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 16(3), 115-119 (1984-03-01)
The hypothesis was made of an increased oxidation of fatty acids (FFA) and a decrease of their esterification rate contributing to the islet secretory defect during starvation. 2-Bromostearate (BrS), a FFA-oxidation inhibitor, was therefore tested on the islet secretion of
Effect of 2-bromostearate on glucose-phosphorylating activities and the dynamics of insulin secretion in islets of Langerhans during fasting.
Bedoya FJ, Ramirez R, Arilla E, Goberna R.
Diabetes, 33, 858-863 (1084)
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
